You are here: Industry Insights > amputation

News List

FDA Removes Amputation Boxed Warning for Canagliflozin americanpharmaceuticalreview
August 28, 2020
Based on a U.S. Food and Drug Administration (FDA) review of new data from three clinical trials, the FDA has removed the Boxed Warning about amputation risk from the diabetes medicine canagliflozin (Invokana, Invokamet, Invokamet XR) prescribing ...
Western Australia aims to reduce amputation rates and improve patient care with state-wide Silhouette(R) implementation En-CPhI.CN
October 24, 2019
ARANZ Medical's Silhouette system is being deployed in Western Australia to improve the care provided for diabetes patients across the entire state.
Risk for Leg Amputation Higher With Microvascular Disease drugs
July 15, 2019
Risk for Leg Amputation Higher With Microvascular Disease.
Hormone Treatment for Prostate Cancer Linked to HSmall Vessel Disease Leaves Patients Vulnerable to Leg Amputation drugs
July 09, 2019
Hormone Treatment for Prostate Cancer Linked to HSmall Vessel Disease Leaves Patients Vulnerable to Leg Amputation.
Decline in Nontraumatic Lower-Extremity Amputation Slowing drugs
June 04, 2019
Decline in Nontraumatic Lower-Extremity Amputation Slowing.
Algae could prevent limb amputation worldpharmanews
March 21, 2019
A new algae-based treatment could reduce the need for amputation in people with critical limb ischaemia, according to new research funded by the British Heart Foundation, published today in the journal npj Regenerative Medicine.
Avacen’s innovation expected to dramatically reduce amputations in India biospectrumasia
July 25, 2017
Initial focus will be to reduce the number of limb amputations resulting from foot ulcers, a common complication associated with diabetes.